globeandmail.com
    globeandmail.com/globe-investor/portfolio-and-tools

RBC Life Science and Technology A
  Profiles Help     Click here to print this page

Fund Sponsor: RBC Global Asset Management Inc.
Portfolio Manager: RBC Global Asset Management Inc.
Fund Type: Open-Ended

Asset Class: U.S. Equity
5-Star Rating:
RRSP Eligible: Yes

Inception Date: July, 1995
Total Assets: $165.80Million  
Sales Fee Type: No Load
Mgmt Expense Ratio (MER): 2.20%
Closed: No

Min. Invest (initial): $500.00
Subsequent: $25.00
Min. Invest (initial RRSP): $500.00
Subsequent RRSP: $25.00
Restricted: No


Statistics


As of January 18, 2018

Current Price: $17.92
Daily Change $: $0.01
1 day: 0.08%
7 day: 1.11%
Month-to-Date: 5.03%
30 day: 0.77%
Year-to-Date: 5.03%

Returns as of December 31, 2017
Fund Group Avg Index*
1 month -2.88% -0.82% -1.66%
3 month 6.11% 6.00% 6.84%
6 month 9.04% 7.70% 7.50%
1 year 22.08% 13.35% 13.83%
3 year 13.82% 9.74% 14.37%
5 year 22.77% 16.31% 21.24%
10 year 11.18% 6.99% 11.12%
15 year 7.42% 5.96% 8.24%
20 year 3.87% 4.21% n/a
Since Inception 5.48% n/a n/a
3 year risk 16.54 11.81 11.10
3 year beta 1.36 0.85 1.00
* Index refers to S&P 500 TR CAD

Top Holdings as of Sep 29, 2017
Apple Inc       9.80%
Microsoft Corp Ord       7.41%
Google Inc Cl A Ord       7.34%
Facebook Inc Ord       5.24%
Johnson & Johnson Ord       3.60%
Visa Inc Ord       2.70%
Pfizer Inc Ord       2.62%
Unitedhealth Group Inc Ord       2.57%
Oracle Corp Ord       2.13%
Intel Corp Ord       1.95%
Extras

Fund Report
Review and compare the current price and performance of all RBC Global Asset Management Inc.

Charting
Generate different performance charts for this Mutual Fund

PDF Fund Profile
Generate a full-color, print-ready profile in PDF format for this Mutual Fund

Fund Codes & Fees
View fund code, load type, trailer fee and fee schedule data for this Mutual Fund.

Fund Price History
View a 30-day price history for this fund


Investment Objectives
To provide long-term capital growth. The fund invests primarily in equity securities of U.S. companies whose businesses relate to life sciences and technology and are expected to benefit from scientific and technological advances.

Portfolio Composition
as of Sep 29, 2017

Sector Weightings
as of Sep 29, 2017

Stock 98.58% Information Technology 65.37%
Cash and Short Term Securities 1.42% Health Care 33.14%
Bond 0.00% Telecommunication Services 0.07%

Portfolio Manager(s)

Ray Mawhinney Manager
RBC Global Asset Management Inc.
Start Date: October, 2007
Fund Return: 10.68%
Ray graduated from the University of Manitoba with a Bachelor of Commerce degree in honours Finance and is a member of the Financial Analysts Federation. As Chair of the RBC Asset Management Inc. (RBC AM) U.S. Equity committee, Ray and his team of experts are responsible for managing the U.S. equity investment activities. Ray is also a member of our Equity Advisory Team.
Also manages: RBC U.S. Equity A, RBC U.S. Equity Cl A, RBC U.S. Equity Cl A USD, RBC U.S. Equity Cl Adv USD, RBC U.S. Equity Cl D USD, RBC U.S. Equity Cl O, RBC U.S. Equity Curr Neut O, RBC U.S. Equity F USD, RBC U.S. Equity O, RBC U.S. Equity O USD